Company Projected Revenue: OraSure Technologies, Inc. (OSUR)

OSUR (OraSure) - company brandmark

Organic margin stabilization following an asset portfolio shift defines the current trend, where the company's projected sales figures visualize business resilience. Confidence in the accuracy of OraSure Technologies (OSUR) rapid diagnostics supports growth, although geopolitical logistics disruptions create supply risks. The current value of 0.12 determines the metric's magnitude, marking the final point of this price action on the chart.

OSUR - OraSure Technologies Projected Sales Volume over the range 07/04/2022 - 11/15/2026

Analytical breakdowns for OraSure Technologies

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Fundamental valuation:OraSure Corp
Product sample of OraSure Technologies Inc

Future sales volume reflects the market consensus for expected revenue, linking the current quote to fundamental business growth forecasts between quarterly reports. By analyzing the current sales forecast level, an investor can decouple stable demand for HIV diagnostics from volatile clinical trial revenues, allowing for an objective assessment of the resilience of OraSure Technologies (OSUR) to economic cycles.

Competitors of OraSure Technologies (OSUR)

Company Projected Revenue Agilent (A)|Projected Sales Volume Quest Diagnostics Incorporated (DGX)|Company Projected Revenue Illumina Corp ILMN|EXAS: Company Revenue Forecast|RVTY: Company Future Sales Volume|Company Sales Forecast bio-rad.com (BIO)|NNNN: Projected Sales Volume|Sotera Health - Company Future Revenue|QDEL (quidel.com) - Projected Sales Volume|OPK: Company Future Revenue|Company Future Sales Volume CDNA (CareDx)|Projected Sales Volume Maravai LifeSciences (MRVI)|Fulgent Genetics, Inc. - Company Future Sales Volume|LAB: Company Revenue Forecast|Cytek Corp - Projected Sales Volume|XGN (exagen.com) - Company Revenue Forecast|MDXH: Projected Sales Volume|Lucid Diagnostics Inc. (LUCD) - Projected Sales Volume|PRE (Prenetics Global) - Projected Sales Volume|Company Expected Sales Volume imdxinc.com IMDX|Company Projected Revenue Trinity Biotech plc (TRIB)|Projected Sales Volume ProPhase (PRPH)|Projected Sales Volume AIMD (ainos.com)|Company Future Sales Co-Diagnostics, Inc. (CODX)|heartsciences.com - Projected Sales Volume|Biomerica, Inc (BMRA) - Company Future Sales Volume|Cardio Diagnostics (CDIO) - Company Projected Revenue|ONCO - Company Future Sales|VRAX (Virax Biolabs Corp) - Projected Sales Volume|Bluejay Diagnostics, Inc. (BJDX) - Company Future Sales|Projected Sales Volume AWH|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD